ChemDiv and Achaogen Enter Into a Discovery Collaboration
04-Feb-2008
ChemDiv, Inc. has announced that it has entered into a discovery collaboration with Achaogen, Inc. Applying its expertise in medicinal and synthetic chemistry, ChemDiv will support Achaogen in identifying and developing novel antibacterial compounds. Financial terms of the collaboration were not disclosed.
"We look forward to collaborating with Achaogen on this exciting project where ChemDiv's strong medicinal chemistry expertise and integrated drug discovery capabilities will provide our partner with the tools for successful research operations and help them achieve rapid progress in this area," said Alex Khvat, Sr. Director of Chemistry at ChemDiv, Inc.
Other news from the department business & finance
